N-Acetyl-Cysteine as Adjuvant Therapy Accelerates Response in Diabetic Foot Osteomyelitis: Open-Label RCT
An open-label RCT finds N-acetylcysteine speeds the fall in inflammatory markers in diabetic foot osteomyelitis, though clinical outcomes were not measured. PICO summary and commentary.
